| CASE REPORT |
|
| Year : 2023 | Volume
: 11
| Issue : 2 | Page : 164-167 |
|
|
Necrotizing cutaneous zygomycosis by Saksenaea vasiformis in post-COVID-19 individual: A rare case report
S Prasanna1, Mayuri Mahajan2, Nikunja Kumar Das3, Nikhil Mahajan2
1 Department of Microbiology, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Chengalpattu, Tamil Nadu, India
2 Dr. Hedgewar Hospital and Research Centre, Akola, Maharashtra, India
3 Department of Microbiology, D. Y. Patil Medical College Hospital and Research Center, D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
Correspondence Address:
S Prasanna
Department of Microbiology, Shri Sathya Sai Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Chengalpattu - 603 108, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mjhs.mjhs_146_22
|
|
|
We report a rare case of cutaneous zygomycosis by Saksenaea vasiformis in post-COVID-19 individuals. A 55-year-old patient was COVID-19 positive and treated as per the protocols. Following recovery after 5 weeks, presents to the surgery outpatient department with complaints of slowly progressive cutaneous lesion developed into ulcerative lesion over the left lateral part of the abdomen, hip, and thigh. Based on histopathological and microbiological findings, he was diagnosed with as a case of cutaneous zygomycosis by S. vasiformis. Initially, conservative management with intravenous amphotericin B was given and followed by surgical debridement; later, the patient succumbed. In general, mucormycosis is associated with immunosuppression or debilitating diseases. The mode of entry for molds and spores of zygomycetes is through the respiratory tract through the nose and then reaches the sinuses, orbit, and intracranial structures. Hence, early clinical diagnosis, direct smears, and proper interventions lead to a good prognosis and reduced morbidity caused by zygomycosis. The therapeutic management of fungal infection is quite challenging; hence diagnosing zygomycosis at the earliest will be appropriate, especially in an immunocompromised state. The misusing of prophylactic drugs, steroids, and immunosuppressants for COVID-19 should be avoided and must be used as per protocol and guidelines.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
